RFNG and colorectal carcinoma: To investigate the underlying mechanism by which RFNG promotes chemoresistance to oxaliplatin in CRC cells, we conducted RNA sequencing (RNA‐seq) analysis of RFNG‐depleted HCT116 cells treated with oxaliplatin.